Involving Patients in Reducing Decision Uncertainties Around Orphan and Ultra-Orphan Drugs: A Rare Opportunity?
Crossref DOI link: https://doi.org/10.1007/s40271-014-0106-8
Published Online: 2014-12-17
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Menon, Devidas
Stafinski, Tania
Dunn, Andrea
Short, Hilary
Text and Data Mining valid from 2014-12-17